Valuation: CellaVision AB

Market Cap 4.2B 420M 370M 350M 318M 596M 40.26B 602M 1.62B 20.56B 1.58B 1.54B 66.16B P/E 2026 *
29.9x
P/E 2027 * 23.7x
Enterprise Value 4.01B 401M 354M 335M 304M 569M 38.46B 575M 1.55B 19.64B 1.51B 1.47B 63.2B EV / Sales 2026 *
5.17x
EV / Sales 2027 * 4.54x
Free-Float
81.06%
Yield 2026 *
1.56%
Yield 2027 * 1.78%
1 day+2.09%
1 week+5.76%
Current month+5.89%
1 month+7.31%
3 months+30.13%
6 months+19.54%
Current year+12.09%
1 week 165.8
Extreme 165.8
180.6
1 month 157
Extreme 157
180.6
Current year 117.6
Extreme 117.6
180.6
1 year 117.6
Extreme 117.6
192.2
3 years 117.6
Extreme 117.6
302
5 years 117.6
Extreme 117.6
459
10 years 75.25
Extreme 75.25
503.5
Manager TitleAgeSince
Chief Executive Officer - 04/06/2026
Director of Finance/CFO 46 01/09/2025
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 61 -
Director/Board Member 62 03/05/2018
Chairman 64 28/04/2021
Date Insider Type Main position Quantity % Market Cap. Importance
14/09/26 Buy

Chief Executive Officer

8,077 0.0339%
02/09/26 Free 100,000 0.4193%
28/04/26 Don

Founder

76,434 0.3205%
Change 5-day change 1-year change 3-year change Capi.($)
+2.09%+5.76%+0.46%+14.71% 420M
-1.33%+2.77%+34.68%-19.20% 18.26B
-0.59%-5.89%-39.43%+24.52% 1.8B
-1.20%-0.64%-30.14%+15.10% 879M
+0.05%-0.05%+52.39%-1.70% 778M
-2.17%-3.15%-63.31%-85.49% 727M
-0.09%-1.05%-30.30%-47.52% 679M
-0.82%-3.67%-44.62%-53.72% 558M
+1.63%+5.99%+45.40%+77.93% 490M
+0.19%-1.67%-53.71%-48.29% 349M
Average +0.13%-0.16%-12.86%-12.37% 2.49B
Weighted average by Cap. +0.30%+1.57%+19.59%-15.69%

Financials

2026 *2027 *
Net sales 777M 77.58M 68.46M 64.78M 58.75M 110M 7.44B 111M 299M 3.8B 291M 285M 12.23B 876M 87.45M 77.18M 73.02M 66.22M 124M 8.39B 125M 338M 4.29B 328M 321M 13.79B
Net income 141M 14.05M 12.39M 11.73M 10.64M 19.94M 1.35B 20.14M 54.22M 688M 52.74M 51.59M 2.21B 179M 17.91M 15.8M 14.95M 13.56M 25.42M 1.72B 25.67M 69.13M 877M 67.24M 65.78M 2.82B
Net Debt -188M -18.75M -16.55M -15.66M -14.2M -26.62M -1.8B -26.89M -72.39M -919M -70.42M -68.88M -2.96B -224M -22.35M -19.73M -18.66M -16.93M -31.73M -2.14B -32.05M -86.29M -1.1B -83.93M -82.1M -3.52B
Logo CellaVision AB
CellaVision AB is a Sweden-based company active in the medical technology sector. The Company develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The Company operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.
Employees
251
Date Price Change Volume
29/09/26 SEK 176.20 +2.09% 26,833
28/09/26 SEK 172.60 -1.26% 39,342
25/09/26 SEK 174.80 +5.05% 29,471
24/09/26 SEK 166.40 -0.95% 9,296
23/09/26 SEK 168.00 +0.84% 51,788
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
176.20SEK
Average target price
180.00SEK
Spread / Average Target
+2.16%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CEVI Stock